Heated chemotherapy for non-muscle-invasive bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial is testing a new device that heats chemotherapy (mitomycin C) directly in the bladder to treat non-muscle-invasive bladder cancer. The goal is to see if this heated chemotherapy is safe and works well enough to help patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years of age or older.
- You must have a diagnosis of non-muscle-invasive bladder cancer (NMIBC) that is considered intermediate-risk or high-risk according to medical guidelines.
- You should be in generally good health, able to perform daily activities with mild to no restrictions (ECOG performance status 0-2).
- Your bladder must be able to hold at least 150 ml of fluid and you must be able to hold urine for more than 1 hour.
- You must not have active urinary tract infection (UTI) or other significant infections.
- You must not have a history of muscle-invasive bladder cancer (cancer that has spread into the bladder muscle) or cancer that has spread to other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving mitomycin directly into the bladder before surgery can help people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this approach is safe and effective at preventing cancer from coming back.
This study compares two approaches for people with early-stage bladder cancer that has a low chance of coming back: either careful monitoring without immediate treatment, or receiving chemotherapy directly into the bladder to lower the risk of recurrence. It aims to see if monitoring alone is as good as chemotherapy for those with a low risk detected by a urine test.
This study tests a treatment called HIVEC, which delivers heated chemotherapy directly into the bladder. It's for people with a certain type of non-muscle-invasive bladder cancer that hasn't gotten better or has come back after BCG treatment, and who can't have or don't want bladder removal surgery.
This trial tests a new treatment called HIVEC (a type of heated chemotherapy placed directly into the bladder) for people with non-muscle-invasive bladder cancer that is at medium or high risk of coming back. It aims to see if this approach can reduce the chance of cancer returning.
This trial tests if you can receive chemotherapy for bladder cancer at home instead of in the clinic. It is for people with early-stage bladder cancer who are already getting certain types of intravesical (inside the bladder) treatment.
This study tests a combination of chemotherapy, immunotherapy, and radiation to treat muscle-invasive bladder cancer while trying to avoid bladder removal. It compares this approach to a watch-and-wait strategy, and also looks at adding maintenance immunotherapy.
Hear when a new Non-muscle Invasive Bladder Cancer (NMIBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.